Valuation GSK plc Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. 2026-09-30			5-day change	1st Jan Change
19,470.00 ^ARS	-2.21%		-2.41%	+4.17%

09-30	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	MT
09-30	Major drugmakers turn to China for licensing deals	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	73,408	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	0.28%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	94,650	91,925	89,105
Change	-	-24.65%	-1.89%	-8.24%	28.83%	7.98%	-2.88%	-3.07%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.2x	11.7x	10.8x
PBR	5.34x	5.47x	4.4x	4.02x	4.51x	4.53x	3.99x	3.53x
PEG	-	0x	-0.2x	-0.4x	0x	-1.64x	0.5x	1.32x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.16x	2.07x	2x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.79x	2.59x	2.43x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.25x	7.49x	7.01x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.18x	8.32x	7.73x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.9x	16.1x	13.4x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.91%	6.23%	7.49%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7494	0.7843
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.8%	4.09%	4.28%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.289	1.566	1.694
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	54%	47.9%	46.3%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,920	35,498	36,615
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,473	12,275	12,711
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,310	11,046	11,531
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,191	6,209	6,755
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	21,242	18,517	15,696
Reference price ²	20.08	14.38	14.50	13.46	18.24	18.32	18.32	18.32
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.9x	11.93x	24.23x	0.6%	1,031B
JOHNSON & JOHNSON	29.45x	6.54x	18.31x	2.02%	638B
ABBVIE INC.	33.1x	7.75x	16.02x	2.65%	462B
MERCK & CO., INC.	105.72x	5.91x	25.05x	2.35%	359B
ROCHE HOLDING AG	19x	4.63x	11.48x	2.87%	335B
NOVARTIS AG	20.37x	5.28x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.79x	4.31x	12.28x	2.05%	253B
AMGEN INC.	26.62x	6.92x	12.32x	2.39%	228B
GILEAD SCIENCES, INC.	-45.08x	6.57x	25.65x	2.21%	185B
Average	26.98x	6.65x	17.60x	2.24%	418.21B
Weighted average by Cap.	32.10x	7.72x	18.90x	1.92%